GW Cancer Center Participates in 42nd Annual Marine Corps Marathon

Marine Corps Marathon runners
MCM team members Madeline and Maritza DeFreitas (mother and daughter) and Robin Laird and Connor Elliott (mother and son)

The George Washington University (GW) Cancer Center was pleased to participate in the 42nd Annual Marine Corps Marathon (MCM) on October 22, 2017. The MCM is one of the largest in the world with over 30,000 participants and brings together multiple organizations to raise funds for charitable causes like cancer research.

This marked the eighth year that the GW Cancer Center hosted a fundraising team. With 68 participants, including 31 marathon and 37 MCM 10K runners, the team counted many GW students, alumni, and faculty/staff among its members. The team raised more than $44,000 to support the GW Cancer Center's efforts to drive transformational research, personalized cancer therapies, family-centered care, and cancer policy in the nation's capital.

"We are so grateful to the community members who invest in the physical and financial commitment that MCM requires to support our work," said Mandi Pratt-Chapman, MA, associate center director for patient-centered initiatives and health equity at the GW Cancer Center. "Our team members are incredibly dedicated and inspire us to work even harder for a cancer-free future."

The 26.2 mile course through the nation's capital began in front of the Pentagon and made its way around northwest Washington, D.C., before ending at the foot of the Marine Corps War Memorial in Arlington, Virginia. The GW Cancer Center would like to extend its sincerest gratitude to all who participated in the MCM marathon and 10K.

Latest News

What do you get when you combine a love of psychology with a keen interest in medicine? Clinical social worker Jessica Gelfarb knows that answer well. With one foot in both worlds, she helps GW Cancer Center patients navigate their most challenging life journeys. While she guides them through the…
Robert H. Miller’s appointment as interim vice provost for research will further build on progress led by Pamela M. Norris
Vishal Patel, MD, FAAD, FACMS, highlights the evolving role of PD-1 inhibitors in the management of nonmelanoma skin cancers.